Barclays
NMTR

Barclays’s 9 Meters Biopharma NMTR Stock Holding History

Barclays’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5
Closed – – 5256
2022
Q2 		$0 Sell
5
-1,833
-100% -$17.3K ﹤0.01% 5390
2022
Q1 		$22K Buy
+1,838
New +$25.1K ﹤0.01% 4426
2019
Q4 		– Hold
0
– – – 6963
2019
Q3 		– Sell
-12
Closed -$242 – 7265
2019
Q2 		$0 Sell
12
-279
-96% -$8.37K ﹤0.01% 7396
2019
Q1 		$11K Buy
+291
New +$12.6K ﹤0.01% 6537
2018
Q4 		– Sell
-347
Closed -$47K – 7475
2018
Q3 		$47K Buy
347
+277
+396% +$47.6K ﹤0.01% 6119
2018
Q2 		$33K Buy
+70
New +$25.8K ﹤0.01% 5911

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Barclays's NMTR Position: Q3 2022 in Review

Barclays sold out of 9 Meters Biopharma (NMTR) in Q3 2022, closing a stake of 5 shares.

Barclays first reported a position in NMTR in Q2 2018 and held it in 6 quarters. The position peaked at $47K in Q3 2018. 74 funds tracked by Wall St. Rank hold NMTR as of Q3 2022.

  • Barclays reported no remaining 9 Meters Biopharma position as of Q3 2022 after selling out during the quarter.
  • Barclays sold 5 9 Meters Biopharma shares in Q3 2022.
  • Barclays first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 6 quarters.
  • Barclays's 9 Meters Biopharma position peaked at $47K in Q3 2018.
  • 74 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.